Measuring HMGB1 and soluble forms of Toll-like Receptors in patients with migraine, tension-type headache, and stroke

Measuring HMGB1 and soluble forms of Toll-like Receptors in patients with migraine, tension-type headache, and stroke - HMGB1 and soluble Toll-like Receptors in Migraine, tension-type headache, and stroke

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026016

Enrollment

Registered

2017-02-24

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine, tension-type headache, stroke

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Those from whom informed consent is obtained 2. Those who are at least 15 years of age 3. Those who satisfy the diagnostic criteria of migraine or tension-type headache 4. Those who are diagnosed with stroke by radiological examinations, such as MRI and CT

Exclusion criteria

Exclusion criteria: 1. Those who do not agree to join the study 2. Those who are considered as ineligible by the attending physician

Design outcomes

Primary

Measure	Time frame
serum HMGB1 level serum soluble forms of Toll-like Receptors	—

Secondary

Measure	Time frame
Correlations between the above concentrations and disease severity	—

Countries

Japan

Contacts

Public ContactMamoru Shibata

Keio University School of Medicine Department of Neurology

mshibata@a7.keio.jp03-5363-3788

Outcome results